Alambic Investment Management, L.P. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 116 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$69,000
+27.8%
10,900
-15.5%
0.02%
+14.3%
Q2 2016$54,000–12,900–0.01%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders